CVS Health Corporation (CVS): A Bull Case Theory
We came across a bullish thesis on CVS Health Corporation on Microcapexpert’s Substack. In this article, we will summarize the bull’s thesis on CVS.
Cvs Health Corp (CVS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 17,682,374 | $1,197,980,839 | -10% | 4.18% |
| 2. | Glenview Capital Larry Robbins | 11,946,799 | $809,395,632 | 19.9% | |
| 3. | Citadel Investment Group Ken Griffin | 6,260,250 | $424,131,938 | -2% | 0.08% |
| 4. | Harris Associates Natixis Global Asset Management | 5,995,818 | $406,216,698 | +6% | 0.68% |
| 5. | Holocene Advisors Brandon Haley | 5,928,174 | $401,633,789 | +125% | 1.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $63.70 | 1,570 | $100,009.00 | 12,007 | 2025-06-05 | Filing | |
| $66.70 | 30,000 | $2,001,000.00 | 39,356 | 2025-02-18 | Filing | |
| $53.88 | 1,000 | $53,879.00 | 21,630 | 2024-05-02 | Filing | |
| $54.49 | 9,181 | $500,293.81 | 9,356 | 2024-05-02 | Filing | |
| $70.47 | 2,000 | $140,930.00 | 20,630 | 2023-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.67 | 150,000 | $10,000,710.00 | 8,196,799 | 2025-05-06 | Filing | |
| $67.99 | 96,999 | $6,595,272.41 | 8,346,799 | 2025-05-05 | Filing | |
| $67.37 | 1,226,933 | $82,654,672.72 | 8,443,798 | 2025-05-05 | Filing | |
| $69.66 | 373,776 | $26,035,591.55 | 9,670,731 | 2025-05-02 | Filing | |
| $68.38 | 222,556 | $15,218,980.18 | 10,044,507 | 2025-05-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 118,335,394 | $8,017,222,944 | 0.14% | |
| 2. | 112,593,476 | $7,628,207,985 | 0.16% | |
| 3. | 73,459,122 | $4,976,855,516 | 2.84% | |
| 4. | 68,398,405 | $4,633,841,718 | 0.75% | |
| 5. | 57,988,171 | $3,928,698,585 | 0.16% |
News See All
This Under-the-Radar Healthcare Stock Could Be a Solid Income Play
Even during economic downturns, people continue to rely on medications, essential consumer products, and affordable local healthcare.
Wells Fargo Remains Bullish on CVS Health (CVS) With an $84 PT
CVS Health Corporation (NYSE:CVS) is one of the 13 Most Undervalued Retail Stocks to Buy Right Now.
CVS Health Corporation (CVS) Surged on Solid Returns and Better-Than-Expected Guidance
Ariel Investments, an investment management company, released its “Ariel Global Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
13 Most Undervalued Retail Stocks to Buy Right Now
On June 12, CNBC reported that new results from an AlixPartners survey show that most retail executives anticipate President Trump to walk back "reciprocal" tariffs on India, Vietnam, the EU, and the ...
CVS Health Corporation (CVS): Jim Cramer Says You Don't Want Them Buying The Wrong Robots
We recently published a list of Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks.
CVS Health (CVS) Maintains Overweight Rating at Cantor Amid Membership Data Discrepancies
Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on June 4.
Jim Cramer Discusses Melting Trade Tensions & These 12 Stocks
In a recent appearance on Squawk on the Street, Jim Cramer discussed fluctuations in stock market futures.
CVS Health Corporation (CVS) Unveils $20 Billion Plan to Improve Customer Healthcare Experience
CVS Health Corporation (NYSE:CVS) plans to invest $20 billion over the next decade to create a more technology-driven consumer healthcare experience, aiming to ease many of the challenges within the US...
JP Morgan Keeps Faith in UnitedHealth (UNH) Amid Regulatory Reviews
On May 21, after the market closed, the Centers for Medicare and Medicaid Services (CMS) announced an expansion of its risk adjustment data validation (RADV) audits for Medicare Advantage plans.